Published in J Exp Med on March 01, 1972
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med (1983) 1.66
Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest (1990) 1.16
Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease. Clin Exp Immunol (1990) 1.05
Transmission of auto-immune haemolytic anaemia and murine leukaemia virus in NZB-BALB/c hybrid mice. Clin Exp Immunol (1976) 0.95
Specificity of anti-nuclear antibodies induced in F1 mice undergoing the graft-vs-host reaction: isotypes and cross-reactivities. Clin Exp Immunol (1987) 0.92
Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E). Clin Exp Immunol (1986) 0.89
Genetics of experimental lupus nephritis: non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease. Clin Exp Immunol (1989) 0.82
Serum-mediated inhibition of graft-vs.-host reaction. J Exp Med (1975) 0.75
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY. Methods Med Res (1964) 5.87
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet (1970) 3.78
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
The passenger cell concept in transplantation immunology. Cell Immunol (1971) 1.86
Strain C57BL-10ScSn and its congenic resistant sublines. Transplant Proc (1970) 1.84
Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains. J Exp Med (1971) 1.49
Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31
Chronic allogeneic disease. I. Development of glomerulonephritis. J Exp Med (1968) 1.28
Cytolysis of mouse lymph node cells by alloantibody: a comparison of guinea-pig and rabbit complements. Immunology (1969) 1.22
Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science (1970) 1.21
Leucocyte antigens and disease. I. Association of HL-A2 and chronic glomerulonephritis. Br Med J (1969) 1.12
Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature. Am J Med (1971) 1.08
Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation (1995) 5.90
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med (1981) 5.48
Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med (1983) 4.43
Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation (1996) 3.82
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67
Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29
Racial profiling in medical research. N Engl J Med (2001) 3.25
Vulnerable plaque: pathobiology and clinical implications. Ann Intern Med (1998) 3.04
Idiotypic cross-reactions of monoclonal human lupus autoantibodies. J Exp Med (1983) 2.96
Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol (1981) 2.83
Pathology of acute and chronic coronary stenting in humans. Circulation (1999) 2.78
Hybridoma autoantibodies to DNA. J Immunol (1980) 2.76
A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol (1982) 2.74
Jumping genes. N Engl J Med (1995) 2.69
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38
An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med (1980) 2.32
Origins of anti-DNA autoantibodies. J Clin Invest (1985) 2.26
Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation (2001) 2.26
Production of autoantibodies by human-human hybridomas. J Clin Invest (1982) 2.22
The immunoglobulin sequence. I. Arrest by 6-mercaptopurine and restitution by antibody, antigen or splenectomy. J Immunol (1965) 2.18
Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med (1973) 2.15
Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol (1998) 2.12
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group. N Engl J Med (1993) 2.09
Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet (1984) 2.08
TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today (1991) 2.06
A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice. J Immunol (1982) 2.05
Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol (1999) 1.96
Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder. Science (1965) 1.92
Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet (1972) 1.90
A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J Exp Med (1986) 1.87
Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med (1979) 1.87
Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol (1984) 1.85
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci (1999) 1.83
Termination of the respiratory burst in human neutrophils. J Clin Invest (1978) 1.80
The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol (1992) 1.79
Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab (2005) 1.78
Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies. Clin Immunol Immunopathol (1984) 1.76
The insulin-like growth factor axis: A review of atherosclerosis and restenosis. Circ Res (2000) 1.75
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J Exp Med (1983) 1.74
Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke (1997) 1.74
Effects of a positron-emitting vanadium-48 nitinol stent on experimental restenosis in porcine coronary arteries: an injury-response study. Cardiovasc Radiat Med (2001) 1.72
Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest (1998) 1.68
Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. J Immunol (1987) 1.67
Coronary calcium, as determined by electron beam computed tomography, and coronary disease on arteriogram. Effect of patient's sex on diagnosis. Circulation (1995) 1.67
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med (1983) 1.66
A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol (1985) (2000) 1.65
Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc (1995) 1.63
Polymorphisms in human H chain V region genes from the VHIII gene family. J Immunol (1989) 1.62
Synthesis of IgM by cells of NZB and SWR mice and their crosses. J Immunol (1979) 1.62
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J (2000) 1.57
Detection of heart calcification with electron beam CT: interobserver and intraobserver reliability for scoring quantification. Radiology (1994) 1.55
Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice I. Xenotropic virus. J Exp Med (1978) 1.55
Leukemia virus activation in chronic allogeneic disease. Proc Natl Acad Sci U S A (1970) 1.55
Utility of magnetic resonance imaging in diagnosing ulnar neuropathy at the elbow. Clin Neurophysiol (2006) 1.54
Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. J Immunol (1983) 1.53
Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum (1984) 1.53
Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J Cell Biol (1980) 1.52
Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation. J Am Coll Cardiol (2001) 1.52
Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology (1992) 1.51
The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. Clin Haematol (1985) 1.51
Normal mice express idiotypes related to autoantibody idiotypes of lupus mice. Proc Natl Acad Sci U S A (1983) 1.50
Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev (1976) 1.50
Immunologic and genetic factors in autoimmune diseases. N Engl J Med (1984) 1.50
Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies. J Exp Med (1985) 1.49
Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol (1985) 1.49
Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer (1984) 1.49
An algorithm for noninvasive identification of angiographic three-vessel and/or left main coronary artery disease in symptomatic patients on the basis of cardiac risk and electron-beam computed tomographic calcium scores. J Am Coll Cardiol (1999) 1.48
Continuous-scale physical functional performance in healthy older adults: a validation study. Arch Phys Med Rehabil (1996) 1.47
Monoclonal anti-cardiolipin antibodies bind to DNA. Eur J Immunol (1984) 1.47
Chronic allogeneic disease. II. Development of lymphomas. J Exp Med (1970) 1.46
Mendelian segregation of loci controlling xenotropic virus production in NZB crosses. Virology (1977) 1.46
Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest (1992) 1.46
Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr (2001) 1.45
Increased oxidative stress in experimental renovascular hypertension. Hypertension (2001) 1.44
High-frequency representation of a single VH gene in the expressed human B cell repertoire. J Exp Med (1993) 1.44
Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol (1996) 1.43
Malignant lymphoproliferative diseases: interactions between immunological abnormalities and oncogenic viruses. Annu Rev Med (1968) 1.43
Transmyocardial and percutaneous myocardial revascularization: current and future role in the treatment of coronary artery disease. Mayo Clin Proc (1999) 1.40
Immunodeficiency and the pathogenesis of lymphoma and leukemia. Semin Hematol (1978) 1.40
Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol (1998) 1.39
Impact of stent size and indication for stent placement on immediate outcome. Cathet Cardiovasc Diagn (1996) 1.39
Nickel allergy versus nickel tolerance: can oral uptake of nickel protect from sensitization? J Environ Monit (2004) 1.39
Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. II. The viral envelope glycoprotein gp70. J Exp Med (1978) 1.39
Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.38
Splenocyte plaque assay for the detection of murine leukemia virus. Proc Soc Exp Biol Med (1975) 1.37
IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol (1991) 1.37
Effect of ischemia on ventricular contractility in patients with coronary artery disease. Angiology (1990) 1.37